Ashwin N Ananthakrishnan (A N Ananthakrishnan, Ashwin Ananthakrishnan)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 58

Top Topics

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

Digestive diseases and sciences

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (8) (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (8) (2024)
Ashwin N Ananthakrishnan
Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants? Gut (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (8) (2024)
Ashwin N Ananthakrishnan
Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants? Gut 73 (4) (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics 59 (8) (2024)
Ashwin N Ananthakrishnan
Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants? Gut 73 (4) (2024)
Ashwin N Ananthakrishnan
Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants? Gut 73 (4) (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Ashwin N Ananthakrishnan
Inflammatory bowel diseases: are we ready to recommend a preventive diet for infants? Gut 73 (4) (2024)
Victoria Gsenger, Adriana Rodriguez, Elizabeth Araka, Fouzia Oza, Hany Eskarous, Bharati Kochar Ms, Ashwin N Ananthakrishnan
A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease. Inflammatory bowel diseases (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Siddharth Singh, Ashwin N Ananthakrishnan, Reza Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of lymphoma in patients with inflammatory bowel disease in population-based cohort studies. Alimentary pharmacology & therapeutics (2024)
Mohammad Zamani, Shaghayegh Alizadeh-Tabari, Mohammad Hassan Murad, Ashwin N Ananthakrishnan, Fatemeh Malekzadeh, Nicholas J Talley
Meta-analysis: Risk of pancreatic cancer in patients with inflammatory bowel disease. Alimentary pharmacology & therapeutics (2024)
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, null null, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut (2023)
Johannes F Scheid, Basak Eraslan, Andrew Hudak, Eric M Brown, Dallis Sergio, Toni Marie Delorey, Devan Phillips, Ariel Lefkovith, Alison T Jess, Lennard W Duck, Charles O Elson, Hera Vlamakis, Damian Rafal Plichta, Jacques Deguine, Ashwin N Ananthakrishnan, Daniel B Graham, Aviv Regev, Ramnik J Xavier
Remodeling of colon plasma cell repertoire within ulcerative colitis patients. The Journal of experimental medicine 220 (4) (2023)
Katherine M Williams, Prasanna K Challa, Emily W Lopes, Kristin E Burke, Ashwin N Ananthakrishnan, James M Richter, Andrew T Chan, Hamed Khalili
Periodontal disease is not associated with risk of inflammatory bowel disease: Results from two prospective cohort studies in the US. Alimentary pharmacology & therapeutics (2023)
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, null null, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut (2023)
Ashwin N Ananthakrishnan, Raj Desai, Wan-Ju Lee, Jenny Griffith, Naijun Chen, Edward V Loftus
Economic Burden of Fatigue in Inflammatory Bowel Disease. Crohn's & colitis 360 5 (3) (2023)
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, null null, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut (2023)
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, null null, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut (2023)
Qi Yan Ang, Damian Plichta, Sean Kim, Iris Hyun-A Kim, Sadie Gregory, Yan Xia, Helena Lau, Ramnik Xavier, Ashwin N Ananthakrishnan
Differential Impact of Smoking on Methylome and Transcriptome in Crohn's Disease and Ulcerative Colitis. Inflammatory bowel diseases (2023)
Marzieh Akhlaghpour, Talin Haritunians, Shyam K More, Lisa S Thomas, Dalton T Stamps, Shishir Dube, Dalin Li, Shaohong Yang, Carol J Landers, Emebet Mengesha, Hussein Hamade, Ramachandran Murali, Alka A Potdar, Andrea J Wolf, Gregory J Botwin, Michelle Khrom, null null, Ashwin N Ananthakrishnan, William A Faubion, Bana Jabri, Sergio A Lira, Rodney D Newberry, Robert S Sandler, R Balfour Sartor, Ramnik J Xavier, Steven R Brant, Judy H Cho, Richard H Duerr, Mark G Lazarev, John D Rioux, L Philip Schumm, Mark S Silverberg, Karen Zaghiyan, Phillip Fleshner, Gil Y Melmed, Eric A Vasiliauskas, Christina Ha, Shervin Rabizadeh, Gaurav Syal, Nirupama N Bonthala, David A Ziring, Stephan R Targan, Millie D Long, Dermot P B McGovern, Kathrin S Michelsen
Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut (2023)
Johannes F Scheid, Basak Eraslan, Andrew Hudak, Eric M Brown, Dallis Sergio, Toni Marie Delorey, Devan Phillips, Ariel Lefkovith, Alison T Jess, Lennard W Duck, Charles O Elson, Hera Vlamakis, Damian Rafal Plichta, Jacques Deguine, Ashwin N Ananthakrishnan, Daniel B Graham, Aviv Regev, Ramnik J Xavier
Remodeling of colon plasma cell repertoire within ulcerative colitis patients. The Journal of experimental medicine 220 (4) (2023)
Johannes F Scheid, Basak Eraslan, Andrew Hudak, Eric M Brown, Dallis Sergio, Toni Marie Delorey, Devan Phillips, Ariel Lefkovith, Alison T Jess, Lennard W Duck, Charles O Elson, Hera Vlamakis, Damian Rafal Plichta, Jacques Deguine, Ashwin N Ananthakrishnan, Daniel B Graham, Aviv Regev, Ramnik J Xavier
Remodeling of colon plasma cell repertoire within ulcerative colitis patients. The Journal of experimental medicine 220 (4) (2023)
Johannes F Scheid, Basak Eraslan, Andrew Hudak, Eric M Brown, Dallis Sergio, Toni Marie Delorey, Devan Phillips, Ariel Lefkovith, Alison T Jess, Lennard W Duck, Charles O Elson, Hera Vlamakis, Damian Rafal Plichta, Jacques Deguine, Ashwin N Ananthakrishnan, Daniel B Graham, Aviv Regev, Ramnik J Xavier
Remodeling of colon plasma cell repertoire within ulcerative colitis patients. The Journal of experimental medicine 220 (4) (2023)
Johannes F Scheid, Basak Eraslan, Andrew Hudak, Eric M Brown, Dallis Sergio, Toni Marie Delorey, Devan Phillips, Ariel Lefkovith, Alison T Jess, Lennard W Duck, Charles O Elson, Hera Vlamakis, Damian Rafal Plichta, Jacques Deguine, Ashwin N Ananthakrishnan, Daniel B Graham, Aviv Regev, Ramnik J Xavier
Remodeling of colon plasma cell repertoire within ulcerative colitis patients. The Journal of experimental medicine 220 (4) (2023)
Ashwin N Ananthakrishnan
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand? Alimentary pharmacology & therapeutics 57 (1) (2022)
Ashwin N Ananthakrishnan
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand? Alimentary pharmacology & therapeutics 57 (1) (2022)
Emily Walsh Lopes, Simon S M Chan, Mingyang Song, Jonas F Ludvigsson, Niclas Håkansson, Paul Lochhead, Allan Clark, Kristin E Burke, Ashwin N Ananthakrishnan, Amanda J Cross, Domenico Palli, Manuela M Bergmann, James M Richter, Andrew T Chan, Ola Olén, Alicja Wolk, Hamed Khalili, null null
Lifestyle factors for the prevention of inflammatory bowel disease. Gut (2022)
Bharati D Kochar, David Cheng, Tianxi Cai, Ashwin N Ananthakrishnan
Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases. Digestive diseases and sciences 67 (11) (2022)
Ashwin N Ananthakrishnan
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand? Alimentary pharmacology & therapeutics 57 (1) (2022)
Emily Walsh Lopes, Simon S M Chan, Mingyang Song, Jonas F Ludvigsson, Niclas Håkansson, Paul Lochhead, Allan Clark, Kristin E Burke, Ashwin N Ananthakrishnan, Amanda J Cross, Domenico Palli, Manuela M Bergmann, James M Richter, Andrew T Chan, Ola Olén, Alicja Wolk, Hamed Khalili, null null
Lifestyle factors for the prevention of inflammatory bowel disease. Gut (2022)
Ashwin N Ananthakrishnan
Editorial: immunosuppression and SARS-CoV-2 vaccination-where do we stand? Alimentary pharmacology & therapeutics 57 (1) (2022)
Katherine Falloon, Benjamin Cohen, Ashwin N Ananthakrishnan, Edward L Barnes, Abhik Bhattacharya, Jean Frederic Colombel, Raymond K Cross, Marcia S Driscoll, Anthony P Fernandez, Christina Ha, Hans Herfarth, Sara N Horst, Jason Hou, M Elaine Husni, Daniela Kroshinsky, Kristine A Kuhn, Careen Y Lowder, George Martin, Deep Parikh, Christopher J Sayed, Lisa Schocket, Bernadette C Siaton, Priyanka Vedak, Michael H Weisman, Florian Rieders
A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Alimentary pharmacology & therapeutics 55 (9) (2022)
Saranya Sasidharan, Alexa N Sasson, Kevin M Shannon, Ashwin N Ananthakrishnan
Fecal Calprotectin Is a Predictor of Need for Rescue Therapy in Hospitalized Severe Colitis. Inflammatory bowel diseases 28 (12) (2022)
Bharati Kochar Ms, Ariela R Orkaby, Ashwin N Ananthakrishnan, Christine S Ritchie
Frailty in inflammatory bowel diseases: an emerging concept. Therapeutic advances in gastroenterology 14 (2021)
Bharati D Kochar, Winston Cai, Ashwin N Ananthakrishnan
Inflammatory Bowel Disease Patients Who Respond to Treatment with Anti-tumor Necrosis Factor Agents Demonstrate Improvement in Pre-treatment Frailty. Digestive diseases and sciences (2021)
Sudheer Kumar Vuyyuru, Saurabh Kedia, Mani Kalaivani, Pabitra Sahu, Bhaskar Kante, Peeyush Kumar, Mukesh Kumar Ranjan, Govind Kumar Makharia, Ashwin N Ananthakrishnan, Vineet Ahuja
Efficacy and safety of fecal transplantation versus targeted therapies in ulcerative colitis: network meta-analysis. Future microbiology 16 (2021)
Ashwin N Ananthakrishnan
IBD risk prediction using multi-ethnic polygenic risk scores. Nature reviews. Gastroenterology & hepatology 18 (4) (2021)
Nienke Z Borren, Millie D Long, Robert S Sandler, Ashwin N Ananthakrishnan
Longitudinal Trajectory of Fatigue in Patients With Inflammatory Bowel Disease: A Prospective Study. Inflammatory bowel diseases 27 (11) (2021)
Alexa N Sasson, Ashwin N Ananthakrishnan
High Anti-Infliximab Antibody Titers Do Not Impact Response to Subsequent Adalimumab Treatment in Inflammatory Bowel Diseases. Digestive diseases and sciences (2021)
Akshita Gupta, Ashwin N Ananthakrishnan
Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review. Therapeutic advances in gastroenterology 14 (2021)
Kevin Casey, Emily W Lopes, Blake Niccum, Kristin E Burke, Ashwin N Ananthakrishnan, Paul Lochhead, James M Richter, Andrew T Chan, Hamed Khalili
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts. Alimentary pharmacology & therapeutics (2021)
Kelly C Cushing, Ashwin N Ananthakrishnan
Editorial: histologic normalisation in ulcerative colitis. Authors' reply. Alimentary pharmacology & therapeutics 51 (3) (2020)
David Cheng, Ashwin N Ananthakrishnan, Tianxi Cai
Robust and efficient semi-supervised estimation of average treatment effects with application to electronic health records data. Biometrics 77 (2) (2020)
Chun-Han Lo, Hamed Khalili, Paul Lochhead, Mingyang Song, Emily W Lopes, Kristin E Burke, James M Richter, Andrew T Chan, Ashwin N Ananthakrishnan
Immune-mediated diseases and risk of Crohn's disease or ulcerative colitis: a prospective cohort study. Alimentary pharmacology & therapeutics 53 (5) (2020)
Nienke Z Borren, Emma Paulides, Jody L Frinack, Ryan N Olson, Maria Alice V Willrich, C Janneke van der Woude, Ashwin N Ananthakrishnan
Infliximab Trough Levels Are Not Predictive of Relapse in Patients with IBD in Endoscopic Remission: A Multicenter Cohort Study. Digestive diseases and sciences 66 (10) (2020)
Nienke Z Borren, William Tan, Alison T Jess, Pei-Hsuan Mimi Li, John J Garber, Jay Luther, Francis P Colizzo, Hamed Khalili, Ashwin N Ananthakrishnan
Assessment of Body Weight Changes in Patients with Inflammatory Bowel Diseases Initiating Biologic Therapy: A Prospective Cohort Study. Digestive diseases and sciences 65 (12) (2020)
Winston Cai, Andrew Cagan, Zeling He, Ashwin N Ananthakrishnan
A Phenome-Wide Analysis of Healthcare Costs Associated with Inflammatory Bowel Diseases. Digestive diseases and sciences 66 (3) (2020)
Tomer Adar, David M Faleck, Saranya Sasidharan, Kelly Cushing, Nienke Z Borren, Niharika Nalagatla, Ryan C Ungaro, Wayne Sy, Samuel C Owen, Anish Patel, Benjamin L Cohen, Ashwin N Ananthakrishnan
Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study. Alimentary pharmacology & therapeutics 49 (7) (2019)
Alexander Levy, Nienke Z Borren, Benjamin Maxner, William Tan, Danielle Bellavance, Kyle Staller, Daniel Chung, Hamed Khalili, Ashwin N Ananthakrishnan
Cancer risk in microscopic colitis: a retrospective cohort study. BMC gastroenterology 19 (1) (2019)
Jay Luther, Manish Gala, Suraj J Patel, Maneesh Dave, Nynke Borren, Ramnik J Xavier, Ashwin N Ananthakrishnan
Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways. Digestive diseases and sciences 63 (3) (2018)
L Xu, P Lochhead, Y Ko, B Claggett, R W Leong, Ashwin N Ananthakrishnan
Systematic review with meta-analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis. Alimentary pharmacology & therapeutics 46 (9) (2017)
G Conway, G Velonias, E Andrews, J J Garber, V Yajnik, Ashwin N Ananthakrishnan
The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases. Alimentary pharmacology & therapeutics 45 (6) (2017)
A Cholapranee, G S Hazlewood, G G Kaplan, L Peyrin-Biroulet, Ashwin N Ananthakrishnan
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials. Alimentary pharmacology & therapeutics 45 (10) (2017)
Nienke Z Borren, Shadi Ghadermarzi, Susan Hutfless, Ashwin N Ananthakrishnan
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PloS one 12 (5) (2017)
Ashwin N Ananthakrishnan, Atsushi Sakuraba, E L Barnes, J Pekow, L Raffals, M D Long, R S Sandler
The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease. Alimentary pharmacology & therapeutics 46 (2) (2017)
Ashwin N Ananthakrishnan
Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply. Alimentary pharmacology & therapeutics 45 (8) (2017)